Gastric cancer stem cells (GCSCs) generally display lower ROS levels and higher chemoresistance; thus, co-targeting FSP1 and ferroptosis inducers to disrupt redox homeostasis could effectively reduce tumor recurrence risk [66,67]. The gene discussed is AIFM2; the disease is gastric cancer.